United States · FDA National Drug Code directory
ENT Support
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43742-2041_fd47b576-5f8b-4032-8795-968f13d6615b
- Product NDC
- 43742-2041
- Form
- LIQUID
- Composition / generic term
- Pulsatilla (Pratensis), Euphorbium Officinarum, Luffa Operculata, Mercurius Iodatus Ruber, Argentum Nitricum, Hepar Sulphuris Calcareum, Influenzinum (2021-2022), Sinusitisinum, Aspergillus Niger, Candida Albicans, Gallicum Acidum, Mucor Racemosus, Mutabile Bacillus (Bach)
- Labeler
- Deseret Biologicals, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20211122 / 20270805
Source-listed ingredients
- PULSATILLA PRATENSIS WHOLE — 4 [hp_X]/mL
- EUPHORBIA RESINIFERA RESIN — 6 [hp_X]/mL
- LUFFA OPERCULATA FRUIT — 6 [hp_X]/mL
- MERCURIC IODIDE — 8 [hp_X]/mL
- SILVER NITRATE — 10 [hp_X]/mL
- CALCIUM SULFIDE — 10 [hp_X]/mL
- INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) — 12 [hp_X]/mL
- INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) — 12 [hp_X]/mL
- INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED) — 12 [hp_X]/mL
- INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED) — 12 [hp_X]/mL
- SINUSITISINUM — 17 [hp_X]/mL
- ASPERGILLUS NIGER VAR. NIGER — 10 [hp_C]/mL
- CANDIDA ALBICANS — 10 [hp_C]/mL
- GALLIC ACID MONOHYDRATE — 10 [hp_C]/mL
- MUCOR RACEMOSUS — 10 [hp_C]/mL
- ESCHERICHIA COLI — 30 [hp_C]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 mL in 1 BOTTLE, DROPPER (43742-2041-1) · 43742-2041-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →